Pharvaris N.V. Files September 2024 6-K Report

Ticker: PHVS · Form: 6-K · Filed: Sep 5, 2024 · CIK: 1830487

Pharvaris N.V. 6-K Filing Summary
FieldDetail
CompanyPharvaris N.V. (PHVS)
Form Type6-K
Filed DateSep 5, 2024
Risk Levellow
Pages4
Reading Time5 min
Sentimentneutral

Sentiment: neutral

Topics: filing, 6-K, regulatory-update

TL;DR

Pharvaris N.V. (PHVS) filed a standard 6-K report for Sept 2024. No major news, just routine filings.

AI Summary

Pharvaris N.V. filed a Form 6-K on September 5, 2024, reporting for the month of September 2024. The company, previously known as Pharvaris, B.V., is incorporated in P7 and has its principal executive offices in Leiden, The Netherlands. This filing is a routine report for a foreign private issuer.

Why It Matters

This filing provides routine updates for investors and regulatory bodies regarding Pharvaris N.V.'s status as a foreign private issuer. It confirms their ongoing reporting obligations under the Securities Exchange Act of 1934.

Risk Assessment

Risk Level: low — This filing is a routine 6-K report and does not contain specific financial results, material events, or significant strategic updates that would typically impact risk levels.

Key Numbers

  • 001-40010 — SEC File Number (Identifies the company's filing with the SEC.)
  • 20240905 — Filing Date (Date the report was submitted to the SEC.)

Key Players & Entities

  • Pharvaris N.V. (company) — Filer of the 6-K report
  • Pharvaris, B.V. (company) — Former name of the registrant
  • 001-40010 (dollar_amount) — SEC file number
  • 20240905 (dollar_amount) — Filing date

FAQ

What is the purpose of a Form 6-K filing?

A Form 6-K is a report of foreign private issuers which provides information that the registrant makes or is required to make public pursuant to the laws of the registrant's home country or jurisdiction, or files or is required to file with a stock exchange on which the registrant's securities are traded.

When was Pharvaris N.V. previously known by another name?

Pharvaris N.V. was formerly known as Pharvaris, B.V., with a date of name change on 20201029.

What is the principal executive office address of Pharvaris N.V.?

The principal executive office is located at Emmy Noetherweg 2, 2333 BK Leiden, The Netherlands.

Does Pharvaris N.V. file annual reports under Form 20-F?

Yes, Pharvaris N.V. indicates by check mark that it files annual reports under cover of Form 20-F.

What is the SIC code for Pharvaris N.V.?

The Standard Industrial Classification (SIC) code for Pharvaris N.V. is 2834, which corresponds to Pharmaceutical Preparations.

Filing Stats: 1,317 words · 5 min read · ~4 pages · Grade level 11.1 · Accepted 2024-09-05 06:51:14

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. PHARVARIS N.V. Date: September 5, 2024 By: /s/ Berndt Modig Name: Berndt Modig Title: Chief Executive Officer EXHIBIT INDEX Exhibit No. Description 99.1 Bradykinin Symposium Press Release, dated September 5, 2024. 99.2 Deucrictibant OLE/LTE data Press Release, dated September 5, 2024. 99.3 Business Update Press Release, dated September 5, 2024. 99.4 Corporate Presentation, dated September 5, 2024.

View Full Filing

View this 6-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.